Literature DB >> 6493035

Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals.

E F Eriksen, F Melsen, L Mosekilde.   

Abstract

The variations with time in function and morphology at the resorptive site in normal iliac crest trabecular bone were reconstructed from tetracycline double-labeled iliac crest bone biopsies from 20 normal individuals. Resorption depths below osteoclasts, mononuclear cells, and preosteoblast-like cells were measured by counting the number of lamellae of known thickness eroded. Mean resorption depth below osteoclasts was 19.0 (+/- 4.9) micron. Lacunae containing mononuclear cells were deeper (P less than less than 0.0001), with a mean resorption depth of 49.1 (+/- 10.2) micron. The deepest lacunae were lacunae containing preosteoblast-like cells, with a mean resorption depth of 62.6 (+/- 12.5) micron. This depth was significantly deeper (P less than 0.001) than the resorption depth found below mononuclear cells. Median total resorption period was 48 days (31-68; 95% confidence interval). Median osteoclastic function period was 8 days (6-12), median mononuclear cell function period was 34 days (24-48), and median period where preosteoblast-like cells were present in lacunae before matrix synthesis started was 9 days (6-13). Distribution curves describing the occurrence of the three cell types in relation to resorption depth showed that osteoclasts occupied the more superior parts of the resorption lacunae, with mononuclear cells and preosteoblast-like cells situated in the deeper parts. The distribution curves support the hypothesis that osteoclasts precede mononuclear cells, which again precede preosteoblast-like cells. Based on this hypothesis, curves showing the variation in resorption depth with time were constructed in duplicate. Resorption rates were calculated for three periods.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6493035     DOI: 10.1016/0221-8747(84)90065-1

Source DB:  PubMed          Journal:  Metab Bone Dis Relat Res        ISSN: 0221-8747


  25 in total

Review 1.  Mechanisms of bone loss and gain in untreated and treated osteoporosis.

Authors:  Juliet Compston
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  Bone adaptation in osteoporosis.

Authors:  Mei-Shu Shih
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

3.  Age-related changes in resorption cavity characteristics in human trabecular bone.

Authors:  P I Croucher; N J Garrahan; R W Mellish; J E Compston
Journal:  Osteoporos Int       Date:  1991-09       Impact factor: 4.507

4.  Histomorphometric interpretation of bone biopsies for the evaluation of osteoporosis treatment.

Authors:  Juliet E Compston
Journal:  Bonekey Rep       Date:  2012-04-04

5.  The relationship between resorption depth and mean interstitial bone thickness: age-related changes in man.

Authors:  P I Croucher; R W Mellish; S Vedi; N J Garrahan; J E Compston
Journal:  Calcif Tissue Int       Date:  1989-07       Impact factor: 4.333

6.  The effects of 17 beta-estradiol and progestagen on trabecular bone remodeling in oophorectomized dogs.

Authors:  G R Snow; C Anderson
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

7.  A study of lamellar organisation in juvenile and adult human bone.

Authors:  S A Reid
Journal:  Anat Embryol (Berl)       Date:  1986

8.  Tibial stress injuries. An aetiological review for the purposes of guiding management.

Authors:  B R Beck
Journal:  Sports Med       Date:  1998-10       Impact factor: 11.136

9.  Loss of trabeculae by mechano-biological means may explain rapid bone loss in osteoporosis.

Authors:  Brianne M Mulvihill; Laoise M McNamara; Patrick J Prendergast
Journal:  J R Soc Interface       Date:  2008-10-06       Impact factor: 4.118

10.  Cancellous bone resorption in the proximal ilium of the ovariectomized rat.

Authors:  H Devlin; M W Ferguson; D H Carter
Journal:  Calcif Tissue Int       Date:  1990-06       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.